Tag Archives: Infectious Disease

← Older posts Newer posts →

Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs

Vir Biotechnology assembled its pipeline of infectious disease compounds through deal-making with other drug developers, along with financial support from blue-chip venture capital firms and the non-profit Bill & Melinda Gates Foundation. Now the biotech is turning to the public markets for the cash to continue clinical tests of its most advanced drug candidates. San […]

Posted in Boston blog main, National blog main, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs

San Antonio Develops “Action Plan” to Draw Life Sciences Businesses

San Antonio — San Antonio has a new “action plan” for bringing more life sciences businesses and professionals to the city, as well as for retaining those it already has. Economic development groups and city officials have been developing a strategy for boosting the healthcare industry in town for more than a year. BioMed SA, […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Antonio Develops “Action Plan” to Draw Life Sciences Businesses

Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M

Growing up in China, Zhi Hong saw the healthcare challenges of his homeland firsthand. Despite the country’s economic strides, life science innovation there lags advances made in the West, he says. The GlaxoSmithKline veteran now wants to use his experience to adjust the balance. Backed by $260 million in financing, his startup, Brii Biosciences, plans […]

Posted in Boston blog main, National blog main, National top stories, New York blog main, Raleigh-Durham, Raleigh-Durham blog main, Raleigh-Durham top stories, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] A study commissioned by a San Antonio bioscience advocacy group and local economic development officials is calling for the city to place additional focus on initiatives that recruit high-profile biotech executives to the Alamo City, bring in more young researchers, and further develop the healthcare IT industry. […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9

The Medicines Co. has sold a group of three infectious disease drugs to Melinta Therapeutics for $215 million in cash and $55 million in stock, as well as future royalty payments on the three drugs, which are already on the market. The deal is an effort by Parsippany, NJ-based Medicines Co. (NASDAQ: MDCO) to get […]

Posted in National blog main, New York, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9

Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup

To biopharmaceutical companies, FDA approval of a new drug brings the opportunity to sell a product in the biggest pharmaceutical market in the world. But disease knows no borders, and many treatments launched in the U.S. market could also have global applications. George Scangos says he joined Vir Biotechnology to bring new infectious disease therapies […]

Posted in National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup

Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug

Arsanis is joining the IPO queue, filing for a stock offering that would raise cash to support a drug that combines two monoclonal antibodies with the goal of preventing pneumonia infections. The filing comes seven months after the Waltham, MA, company raised $45.5 million in a Series D investment round to finance Phase 2 studies […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, Seattle blog main | Tagged , , , , , , , , , , , , , , , | Comments Off on Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug

Vir Biotech Vies for Global Approach to Tackling Infectious Disease

Vir Biotechnology CEO George Scangos aims to develop new infectious disease drugs that can treat people in the U.S. and other developed countries. But he also wants to make these therapies available to the developing world, where the need is great but the financial means to pay for medicine is scarce. To accomplish both goals, […]

Posted in Boston blog main, National blog main, National top stories, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on Vir Biotech Vies for Global Approach to Tackling Infectious Disease

SRI’s Michigan Office Will Help Develop New VEE Vaccine

SRI International, the Menlo Park, CA-based nonprofit contract research giant, is counting on its Michigan office to play a crucial role in the development of a new vaccine. SRI has been awarded two contracts worth $4.7 million by the U.S. Army’s Joint Vaccine Acquisition Program to test and manufacture a potential new vaccine against Venezuelan equine […]

Posted in Detroit, Detroit blog main, Detroit top stories, National blog main, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on SRI’s Michigan Office Will Help Develop New VEE Vaccine

With Government Backing, Moderna Joins the Zika Vaccine Chase

Moderna Therapeutics, whose unusual and still unproven drug-producing technology has attracted more than a billion dollars in funding and partnerships, is joining the scramble to produce a vaccine to protect against Zika virus infection. The virus, which has gone from a biological afterthought to a global health crisis in a few years, can cause microcephaly, […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , | Comments Off on With Government Backing, Moderna Joins the Zika Vaccine Chase← Older posts Newer posts →